$0.29
arrow_drop_down5.17%Key Stats | |
---|---|
Open | $0.29 |
Prev. Close | $0.30 |
EPS | -2.04 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $15.68M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.29 | 0.31 |
52 Week Range | 0.24 | 1.92 |
Ratios | |
---|---|
Revenue | - |
EPS | -2.04 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'
Analyst Ratings For Cara Therapeutics
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
In-Depth Examination Of 5 Analyst Recommendations For Cara Therapeutics
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
Cara Therapeutics Reports First Quarter 2024 Financial Results